Page last updated: 2024-08-16

ribavirin and Hepatitis E

ribavirin has been researched along with Hepatitis E in 178 studies

Research

Studies (178)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	132 (74.16)	24.3611
2020's	46 (25.84)	2.80

Authors

Authors	Studies
Chan, HSY; Cheng, VCC; Chew, NFS; Fung, KSC; Hon, KL; Leung, AWS; Leung, KH; Lo, KHY; Ng, KHL; Situ, J; Sridhar, S; Tsang, OTY; Tse, CWS; Wong, SCY; Wu, S; Yip, CCY; Yuen, KY	1
Arbiza, J; Cancela, F; Gumbis, G; Houston, DR; Mirazo, S; Panzera, Y; Pérez, R; Quintero-Gil, C; Rendon-Marin, S	1
Dai, L; He, Q; Liang, Z; Lu, F; Shu, J; Wang, L; Zhang, F	1
Bay, JO; Boyer, P; Brebion, A; Carcenac, R; Fayard, A; Henquell, C; Izopet, J; Latour, J; Lhomme, S; Mirafzal, S	1
Boettler, T; Emmerich, F; Fischer, N; Gundlach, S; Hofmann, M; Huang, J; Huzly, D; Kemming, J; Llewellyn-Lacey, S; Lütgehetmann, M; Neumann-Haefelin, C; Panning, M; Pischke, S; Price, DA; Schulze Zur Wiesch, J; Tanriver, Y; Thimme, R; Warnatz, K	1
Cholongitas, E; Markakis, GE; Papatheodoridis, GV	1
Dolman, G; Gelson, W; Mohsen, A; Robins, A; Williams, S	1
Brown, LE; Brüggemann, Y; Kinast, V; Kirschning, A; Klöhn, M; Porco, JA; Praditya, DF; Steinmann, E; Todt, D; Vondran, FWR; Zhang, W	1
Alves, R; Carias, E; Correia, AL; Figueiredo, A; Guedes Marques, M; Leal, R; Leitão, J; Pimenta, AC; Rodrigues, L; Romãozinho, C; Santos, L	1
Adjallé, R; Ayuk, F; Bokemeyer, C; Fiedler, W; Ghandili, S; Kröger, N; Lindhauer, C; Modemann, F; Pischke, S; Polywka, S; Von Kroge, PH; Zur Wiesch, JS	1
Carter, M; Fitzmaurice, MG; Jafri, SM; Nagai, S; Singh, A; Solsrud, K; Yeddula, S	1
Hassebroek, AM; Heffron, CL; Mahsoub, HM; Meng, XJ; Sooryanarain, H; Tian, D; Wang, B	1
Chiu, CY; Hosing, C; Torres, HA; Westin, J; Zhang, HC	1
Azevedo Silva, M; Eliseu, L; Leal, C; Ruge Gonçalves, A	1
Chen, Z; Jiang, L; Liu, C; Tang, Z; Tian, W; Wang, S; Wang, Y; Wei, J; Wen, G; Wu, T; Xia, N; Yan, L; Ying, D; Zhang, M; Zheng, Z	1
Abravanel, F; Del Bello, A; Izopet, J; Kamar, N; Pan, Q	1
Murata, K; Nagashima, S; Okamoto, H; Primadharsini, PP; Takahashi, M	1
Kosone, T; Murata, K; Nagashima, S; Okamoto, H; Takagi, H; Takahashi, M; Takakusagi, S; Yamazaki, Y	1
Adombie, CM; Bosch, A; Buti, M; Campos, C; Colomer-Castell, S; Cortese, MF; Domingo, E; Esteban, JI; Gallego, I; Garcia-Cehic, D; Gregori, J; Guix, S; Ibañez-Lligoña, M; Perales, C; Pintó, R; Quer, J; Rando-Segura, A; Riveiro-Barciela, M; Rodriguez-Frias, F; Tabernero, D	1
Abravanel, F; Izopet, J; Kamar, N; Lhomme, S; Marion, O; Péron, JM	1
Hon, KLE; Leung, AKC; Sridhar, S; Wong, AHC	1
Adenugba, A; Bitterer, F; Geissler, EK; Kupke, P; Schemmerer, M; Schlitt, HJ; Wenzel, JJ; Werner, JM	1
Hassebroek, AM; Heffron, CL; LeRoith, T; Li, W; Mahsoub, HM; Meng, XJ; Tian, D; Wang, B	1
Hui, W; Wei, L	1
Burmeister, T; Hofmann, J; Ingwersen, V; Keller, U; Le Coutre, P; Leng, C; Maschmeyer, G; Muche, M; Schneider, T; Schwartz, S	1
Coelmont, L; Cremers, N; Debing, Y; Hendrickx, S; Kaptein, SJF; Neyts, J; Roskams, T; Zhang, X	1
Baylis, SA; Beheim-Schwarzbach, J; Bleicker, T; Corman, VM; Drosten, C; Hanitsch, LG; Hofmann, J; Jones, TC; Melchert, J; Radbruch, H	1
Nagashima, S; Nishiyama, T; Okamoto, H; Primadharsini, PP	1
Borena, W; Graziadei, I; Oberhuber, G; Wenter, C	1
Forgan-Smith, KR; Macdonald, G	1
Berg, T; Bock, CT; Gerhardt, F; Liebert, UG; Maier, M; Papp, CP; Platzbecker, U; van Bömmel, F; Wang, SY	1
Crum-Cianflone, NF	1
Abravanel, F; Barbet, C; Behrendt, P; Cassuto, E; Choi, M; Coilly, A; Couzi, L; De Man, RA; Dharancy, S; Donnelly, MC; Dumortier, J; Elsharkawy, AM; Etienne, I; Figueres, L; Garrouste, C; Glowaki, F; Hillaire, S; Hofmann, J; Horvatits, T; Izopet, J; Kamar, N; Lebray, P; Marion, O; Matignon, M; Minello, A; Moal, V; Mousson, C; Pageaux, GP; Perrin, P; Radenne, S; Rerolle, JP; Riezebos-Brilman, A; Sayegh, J; Scemla, A	1
Costa, J; Forns, X; García-López, M; Lens, S; Navasa, M; Pérez-Del-Pulgar, S; Sastre, L	1
Dalton, HR; Donnelly, M; Fraser, A; Guaci, J; Gunson, R; Hussaini, SH; Kemp, L; Lin, N; Miller, M; Murray, A; Simpson, K; Spoor, J; Stanley, A; Swann, R; Wallace, SJ	1
Casper, M; Grünhage, F; Lammert, F; Reichert, MC; Rissland, J	1
Ami, Y; Doan, YH; Jirintai, S; Li, TC; Muramatsu, M; Okamoto, H; Suzaki, Y; Takahashi, M; Takeda, N; Zhang, W	1
Allaire, M; Dao, T; Lebedel, L; Lecouf, A; Lier, C; Nguyen, TTN; Ollivier-Hourmand, I	1
Aslan, AT; Balaban, HY	1
de Bruijne, J; de Man, RA; de Winter, BCM; Durmaz, G; Gandia, P; Hesselink, DA; Izopet, J; Kamar, N; Mulder, MB; van der Eijk, AA; van Gelder, T; Vanwolleghem, T	1
de Man, RA; Kainov, DE; Li, P; Li, Y; Ma, Z; Pan, Q; Peppelenbosch, MP; Yu, P; Zhang, R	1
Chacra, W; Chan, C; Choi, DK; Koppe, S; Landers, L; Martin, MT; Mikolajczyk, AE; Naveed, A	1
Estévez Escobar, M; Gómez Torres, KM; Lozano Serrano, AB	1
de Bruijne, J; Gorris, M; van der Lecq, BM; van Erpecum, KJ	1
Dhanda, A; Moodley, P; Whyte, AF	1
Abravanel, F; Larrue, H; Peron, JM	1
Ami, Y; Doan, YH; Li, TC; Muramatsu, M; Suzaki, Y; Takeda, N; Zhang, W	1
Bowden, S; Faddy, HM; Gibbs, T; Hoad, VC; Levy, A; Mews, C; Nash, M; Perkowska-Guse, Z; Ravikumara, M; Tracy, SL	1
Crossan, CL; Dalton, H; Donnelly, MC; Hayes, PC; Scobie, L; Simpson, KJ	1
Akhavan, S; Calin, R; Demeret, S; Jaspard, M; Katlama, C; Mallet, V; Peytavin, G; Pourcher, V; Poynard, T; Roque-Afonso, AM; Thibault, V; Todesco, E	1
Wedemeyer, H	1
Gorard, D; Rait, S; Shahid, S; Sharples, E	1
Descalzi, VI; González, J; Gruz, F; Lizarraga Villagran, MA; Munné, MS; Raffaele, PP	1
Andrews, PA; Ankcorn, M; Elsharkawy, AM; Ijaz, S; McPherson, S; Powell, J; Rowe, I; Tedder, R	1
Abravanel, F; Barragué, H; Champagne, E; Condat, B; Izopet, J; Petitdidier, N; Renou, C	1
Abravanel, F; Belliere, J; Cintas, P; Cointault, O; Faguer, S; Izopet, J; Kamar, N; Lavayssière, L; Lhomme, S; Martinez, S; Nogier, MB	1
Chan, JFW; Huang, C; Hung, IFN; Lau, SKP; Sridhar, S; Tang, SCW; Teng, JLL; Woo, PCY; Yap, DYH; Yip, CCY; Yuen, KY	1
Aggarwal, R; Dalton, HR; Izopet, J; Kamar, N; Labrique, A; Pavio, N; Wedemeyer, H	1
Douthwaite, S; Evans, TJ; Hilton, R	1
Chen, G; Pan, Q; Wang, Y; Zhao, J	1
De Winter, BCM; Hesselink, DA; Kamar, N	1
Abravanel, F; Akhavan, S; Calmus, Y; Conti, F; Guillemain, R; Lecuyer, L; Marcelin, AG; Mazzola, A; Peytavin, G; Poynard, T; Roque-Afonso, AM; Todesco, E	1
de Mello, VDM; Gardinali, NR; Leal, M; Lewis-Ximenez, LL; Melgaço, JG; Pinto, MA	1
Häffner, K; Klämbt, V; Panning, M; Pohl, M; Seidl, M	1
Kamar, N; Pischke, S	1
Albillos Martínez, A; Flores de Miguel, A; Guerrero García, A; Ríos León, R; Rodríguez de Santiago, E; Rodríguez Gandía, MA; Sánchez Rodríguez, E; Tenorio Cañamás, MT	1
Abravanel, F; Alric, L; Del Bello, A; Esposito, L; Faguer, S; Izopet, J; Kamar, N; Lhomme, S; Marion, O; Puissant-Lubrano, B	1
Díaz, A; Jung, G; Lens, S; Olivas, P	1
Biliotti, E; De Angelis, M; Esvan, R; Franchi, C; Garbuglia, AR; Palazzo, D; Spaziante, M; Taliani, G; Volpicelli, L	1
Behrendt, P; Dao Thi, VL; Engelmann, M; Friesland, M; Kinast, V; Meuleman, P; Moeller, N; Praditya, D; Sayed, IM; Steinmann, E; Todt, D; Verhoye, L	1
Bes, M; Buti, M; Esteban, R; Gregori, J; Llorens, M; Piriz, S; Piron, M; Quer, J; Riveiro-Barciela, M; Salcedo, MT; Sauleda, S; Valcarcel, D	1
Meister, TL; Steinmann, E; Todt, D	1
Drinane, M; Jing Wang, X; Watt, K	1
Abravanel, F; Cointault, O; Del Bello, A; Esposito, L; Hébral, AL; Izopet, J; Kamar, N; Lavayssière, L; Lhomme, S; Marion, O; Ribes, D	1
Bladé, JS; Boudin, L; de Jauréguiberry, JP; Patient, M; Roméo, E; Tsitsi Nding Tsogou, P	1
Abravanel, F; Izopet, J; Kamar, N; Marion, O	1
Kamar, N; Pan, Q	1
Drinane, M	1
Diepolder, H	1
Izopet, J; Kamar, N; Marion, O	1
Aguado, S; Aguilar, M; Ambrocio, GPL; Aran-Toha, G; Avellon, A; Carrillo, J; Laporta, R; Lazaro-Carrasco, M; Ussetti, M	1
Ackermann, J; Eisenberger, U; Fiedler, M; Friebus-Kardash, J; Kribben, A; Rohn, H; Wenzel, J; Witzke, O	1
Abravanel, F; Alric, L; Bellière, J; Del Bello, A; Izopet, J; Kamar, N; Lavayssiere, L; Lhomme, S	1
Abravanel, F; Cocquerel, L; Izopet, J; Meuleman, P; Montpellier, C; Sayed, IM; Verhoye, L	1
Bock, CT; Eurich, D; Gerlach, UA; Hofmann, J; Maurer, MM; Mueller, T; Papp, CP; Schulz, M	1
Aitken, C; Alric, L; Ayuk, F; Bettinger, D; Binder, M; Cornelissen, JJ; de Man, RA; Giordani, MT; Lohse, AW; Mallet, V; Pischke, S; Schlabe, S; Schnitzler, P; Spengler, U; Thimme, R; von Felden, J; Xhaard, A	1
Addo, MM; Frerk, S; Horvatits, T; Lohse, AW; Lübke, R; Luetgehetmann, M; Pischke, S; Reucher, S; Schneider, SW; Schulze Zur Wiesch, J; Varwig-Janssen, D	1
Chtioui, H; Fraga, M; Gouttenoire, J; Marcu, C; Moradpour, D; Pascual, M; Sahli, R; Vionnet, J	1
Burkard, TL; Kinast, V; Steinmann, E; Todt, D	1
Wahid, B	1
Horvatits, T; Lohse, AW; Lütgehetmann, M; Pischke, S; Schulze Zur Wiesch, J	1
Abravanel, F; Huynh, A; Konopacki, J; Latour, RP; Lissandre, S; Mallet, V; Nguyen-Quoc, S; Ribaud, P; Rohrlich, PS; Roque-Afonso, AM; Tabrizi, R; Xhaard, A	1
Abravanel, F; Cotler, SJ; Dahari, H; DebRoy, S; Dimeglio, C; Izopet, J; Kamar, N; Lhomme, S; Marion, O; Metsu, D	1
Colson, P; Decoster, C	1
Basho, K; Fahrner, A; Neumann-Haefelin, C; Panning, M	1
Bara, CL; Birkner, S; Bode, U; Chatzikyrkou, C; Gottlieb, J; Hardtke, S; Kauffmann, W; Manns, MP; Pischke, S; Wedemeyer, H; Wenzel, J	1
Colson, P; Gérolami, R; Hajji, H; Moreau, J; Solas, C	1
Baumann, U; Goldschmidt, I; Junge, N; Manns, M; Pfister, ED; Pischke, S; Wedemeyer, H	1
Avellón, A; Barreiro, P; Cifuentes, C; Echevarría, JM; Macías, J; Martín-Carbonero, L; Neukam, K; Pineda, JA; Soriano, V; Vargas, J	1
Parvez, MK	1
Rakela, J; Unzueta, A	1
Abbas, Z; Afzal, R	1
Debing, Y; Neyts, J	1
Bremer, B; Gisa, A; Gottlieb, J; Greer, M; Hardtke, S; Haverich, A; Lehmann, P; Manns, MP; Pischke, S; Wedemeyer, H; Welte, T	1
Ambrosioni, J; Bernimoulin, M; Hadengue, A; Kaiser, L; Landelle, C; Mamin, A; Negro, F; Samii, K	1
Herbst, DA; Pavri, TM; Reddy, KR	1
Chen, K; Debing, Y; Janssen, HL; Metselaar, HJ; Neyts, J; Pan, Q; Peppelenbosch, MP; Van Der Laan, LJ; Wang, Y; Zhou, X	1
Bertuzzo, VR; Calderaro, A; Morelli, MC; Pinna, AD; Ravaioli, M; Viale, P	1
Buti, M; Gironés, R; Mínguez, B; Quer, J; Riveiro-Barciela, M; Rodriguez-Frías, F	1
Abravanel, F; Bismuth, M; Buchler, M; Coilly, A; Couzi, L; D'Alteroche, L; Dharancy, S; Dumortier, J; Garrigue, V; Hillaire, S; Hourmant, M; Izopet, J; Kamar, N; Lebray, P; Mallet, V; Minello, A; Pol, S; Radenne, S; Roque-Afonso, AM; Rostaing, L; Tripon, S	1
Thomas, DL	1
Bahra, M; Hofmann, J; Klein, F; Neuhaus, P; Neuhaus, R; Rudolph, B	1
Boots, JM; de Man, R; de Vries, MA; Samijn, JP	1
Bani-Sadr, F; Brodard, V; Ehrhard, F; Hentzien, M; Izopet, J; Lambert, D; Lebrun, D; Nguyen, Y; Peron, JM; Robbins, A; Tabary, T	1
Howard, M; Jackson, N; Lim, KH; Verma, S	1
Izopet, J; Kamar, N; Mallet, V	1
Harrabi, H; Maaloul, I	1
Brochot, E; Choukroun, G; Duverlie, G	1
Hung, CC; Lee, KY	1
Bremer, B; Dallmeier, K; Debing, Y; Gisa, A; Manns, M; Neyts, J; Pischke, S; Suneetha, PV; Wedemeyer, H	1
Behrendt, P; Bock, CT; Jilg, W; Manns, MP; Pischke, S; Wedemeyer, H	1
Abravanel, F; Izopet, J; Kamar, N; Lhomme, S; Rostaing, L	1
Capón, A; Costa, J; Forns, X; Gambato, M; González, P; Lens, S; Londoño, MC; Mariño, Z; Mensa, L; Navasa, M; Pérez-del-Pulgar, S; Soriano, G; Torras, X	1
Abravanel, F; Izopet, J; Kamar, N; Lhomme, S; Roque, AM	1
Del Bello, A; Guilbeau-Frugier, C; Izopet, J; Josse, AG; Kamar, N; Rostaing, L	1
Adams, L; Bowden, S; de Boer, B; Faddy, HM; Ma, MX; MacNicholas, R; MacQuillan, G; Nash, M; Speers, DJ	1
Antón, MD; Cuchillo, H; Ferrando, I; Kanter, J; Moreno, E; Moreno, N; Roselló, E	1
Drenth, JP; Gevers, TJ; Peters van Ton, AM	1
Abravanel, F; Bauer, H; Cantagrel, A; Chatelus, E; Claudepierre, P; Fabre, S; Fournier, S; Gottenberg, JE; Hudry, C; Izopet, J; Lefevre, G; Luxembourger, C; Marguerie, L; Martin, A; Messer, L; Molto, A; Pallot-Prades, B; Péron, JM; Pers, YM; Roque-Afonso, AM; Roux, C; Sibilia, J; Sordet, C; Soubrier, M; Veissier, C; Wendling, D	1
Emmerich, F; Panning, M; Umhau, M	1
Pischke, S; Wedemeyer, H	1
Dienes, HP; Galante, A; Gisa, A; Hiller, J; Lohse, AW; Luetgehethmann, M; Nashan, B; Pischke, S; Polywka, S; Sterneck, M; Suneetha, PV	1
Abravanel, F; Alric, L; Anty, R; Bureau, C; Gérolami, R; Guillaume, M; Izopet, J; Kamar, N; Nana, J; Pariente, A; Péron, JM; Renou, C; Robic, MA; Vinel, JP	1
Abravanel, F; Alric, L; Beyne-Rauzy, O; Faguer, S; Gaudin, C; Huguet, F; Huynh, A; Kamar, N; Oberic, L; Peron, JM; Recher, C; Roussel, M; Tavitian, S; Ysebaert, L	1
Abravanel, F; Broué, P; Cardeau-Desangles, I; Cointault, O; Del Bello, A; Dörr, G; Esposito, L; Goin, AL; Guitard, J; Izopet, J; Kamar, N; Lavayssière, L; Lhomme, S; Metsu, D; Nogier, MB; Ribes, D; Rostaing, L; Sauné, K	1
Kotton, CN	1
Ho, CM; Hu, RH; Lee, PH; Sun, HY; Tsai, JH; Wu, CH	1
Castedal, M; Karason, K; Konar, J; Lagging, M; Norder, H; Waldenström, J	1
Akhavan, S; Charlotte, F; Mallet, M; Mouri, S; Poynard, T; Rudler, M; Thabut, D; Thibault, V	1
Khuroo, MS	1
Dao Thi, VL; Debing, Y; Gouttenoire, J; Moradpour, D; Neyts, J; Rice, CM; Wu, X	1
Dollenmaier, G; Krayenbühl, PA; Mani, B; Sahli, R; Schultze, D; Zbinden, A	1
Metselaar, HJ; Pan, Q; Peppelenbosch, MP; Sprengers, D; Wang, W; Wang, Y; Xu, L; Zhou, X	1
Acosta Materan, R; Martín Arribas, MI; Mora Soler, AM; Pérez Corte, D; Revilla Morato, C; Rodríguez Pérez, A; Velasco-Guardado, A	1
Abravanel, F; Alessandri-Gradt, E; Barth, H; Bismuth, M; Carcenac, R; Dubois, M; Ducos, J; Garrigue, V; Goria, O; Izopet, J; Jeanne, N; Kamar, N; Lefebvre, C; Lhomme, S; Nicot, F; Ollivier, I; Perrin, P; Petitjean-Lecherbonnier, J; Saune, K	1
Abravanel, F; Blasco-Baque, V; Blasco-Perrin, H; Péron, JM	1
Mallet, V; Pol, S; Roque-Afonso, AM; Sberro-Soussan, R; Vallet-Pichard, A	1
Debing, Y; Gouttenoire, J; Moradpour, D; Neyts, J	1
Abravanel, F; Cocquerel, L; Debing, Y; Dubuisson, J; Farhoudi, A; Foquet, L; Izopet, J; Leroux-Roels, G; Meuleman, P; Michiels, T; Montpellier, C; Neyts, J; Sayed, IM; Verhoye, L; Wychowski, C	1
Herbst, H; Ingiliz, P; Mayr, C; Obermeier, M; Pischke, S; Polywka, S	1
Di Martino, V; Prati, C; Thevenot, T; Verhoeven, F; Weil-Verhoeven, D; Wendling, D	1
Behrendt, P; Bock, CT; Bremer, B; Brown, RJ; Cornberg, M; Gisa, A; Manns, MP; Nitsche, A; Pischke, S; Radonic, A; Steinmann, E; Suneetha, PV; Todt, D; Wedemeyer, H	1
Almeida-Santos, M; Barroso, E; Carmo, J; Curran, M; Marques, S; Mateus, É; Morbey, A; Veloso, J	1
Gouttenoire, J; Moradpour, D; Szkolnicka, D	1
Attarian, S; Borentain, P; Colson, P; Gérolami, R; Sevy, A; Sicello, M	1
Abravanel, F; Alric, L; Izopet, J; Kamar, N; Lhomme, S; Marion, O; Peron, JM	1
Dalton, HR; Kamar, N	1
Kater, AP; Schinkel, J; van der Valk, M; Zaaijer, HL	1
Brown, RJ; Steinmann, E; Todt, D; Walter, S	1
Gilgenkrantz, H; Gouttenoire, J; Mallet, V	1
Hartl, J; Pischke, S; Wehmeyer, MH	1
Behrendt, P; Brown, RJ; Dammermann, W; Drave, S; Iking-Konert, C; Lüth, S; Pischke, S; Schnoor, U; Steinmann, E; Todt, D; Wedemeyer, H	1
Ledeboer, M; Martens, HA; van Bijnen, ST	1
Decaens, T; Larrat, S; Loyrion, E; Payen, JF; Pouzol, P; Trouve-Buisson, T	1
Alric, L; Aronica, EMA; Ayo-Martin, AC; Cao, W; Dalton, HR; de Man, RA; de Vrij, FMS; de Zeeuw, CI; Huang, F; Jacobs, BC; Kamar, N; Kushner, SA; Lin, Z; Marie Peron, J; Metselaar, HJ; Pan, Q; Peppelenbosch, MP; Sprengers, D; van der Kroeg, M; van Eijk, JJ; Wang, W; Wang, Y; Xu, L; Yin, Y; Zhao, M; Zhou, X	1
Roberts, EA; Yeung, LT	1
Chakvetadze, C; Mallet, V; Mouthon, L; Nicand, E; Pol, S; Sogni, P; Sultanik, P; Tessé, S; Thervet, E	1
Nau, JY	1
Abravanel, F; Alric, L; Basse, G; Cointault, O; Esposito, L; Garrouste, C; Izopet, J; Kamar, N; Lhomme, S; Nogier, MB; Peron, JM; Ribes, D; Rostaing, L	1
Dalton, H; Izopet, J; Kamar, N; Péron, JM	1
Chaillon, A; d'Alteroche, L; De Muret, A; Goudeau, A; Nicand, E; Sirinelli, A	1
Borentain, P; Colson, P; Gerolami, R; Motte, A; Raissouni, F; Solas, C	1
Alric, L; Beynes-Rauzy, O; Bonnet, D; Izopet, J; Kamar, N	1
Bendall, R; Dalton, HR; Ijaz, S; Keane, FE; Mathew, J	1
Arné-Bes, MC; Del Bello, A; Kamar, N; Lavayssière, L	1
Beuers, U; de Niet, A; Reesink, HW; ten Berge, I; Weegink, CJ; Zaaijer, HL	1
Acharya, SK; Goyal, R; Kumar, A; Panda, SK; Paul, SB	1
Anty, R; Euller-Ziegler, L; Patouraux, S; Roux, CH	1

Reviews

30 review(s) available for ribavirin and Hepatitis E

Article	Year
Epidemiology and treatment of hepatitis E in the liver transplantation setting: A literature review. Journal of viral hepatitis, 2022, Volume: 29, Issue:9 Topics: Hepatitis E; Hepatitis E virus; Humans; Immunocompromised Host; Liver Transplantation; Ribavirin; RNA; RNA, Viral	2022
Hepatitis E virus and Zoonosis: Recent Advances and Therapeutic Implications. Recent advances in inflammation & allergy drug discovery, 2023, Volume: 17, Issue:1 Topics: Animals; Female; Hepatitis A; Hepatitis E; Hepatitis E virus; Humans; Pregnancy; Rats; Ribavirin; Sofosbuvir; Zoonoses	2023
Three Distinct Reporter Systems of Hepatitis E Virus and Their Utility as Drug Screening Platforms. Viruses, 2023, 09-23, Volume: 15, Issue:10 Topics: Antiviral Agents; Drug Evaluation, Preclinical; Hepatitis E; Hepatitis E virus; Humans; Ribavirin; Virus Replication	2023
Hepatitis E virus: Epidemiology, diagnosis, clinical manifestations, and treatment. World journal of gastroenterology, 2020, Oct-07, Volume: 26, Issue:37 Topics: Aged; Aged, 80 and over; Animals; Antiviral Agents; Female; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Humans; Pregnancy; Ribavirin; Swine	2020
Treatment for chronic hepatitis E virus infection: A systematic review and meta-analysis. Journal of viral hepatitis, 2021, Volume: 28, Issue:3 Topics: Antiviral Agents; Drug Therapy, Combination; Hepacivirus; Hepatitis E; Hepatitis E virus; Humans; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome	2021
Review article: hepatitis E-a concise review of virology, epidemiology, clinical presentation and therapy. Alimentary pharmacology & therapeutics, 2017, Volume: 46, Issue:2 Topics: Acute Disease; Blood Transfusion; Foodborne Diseases; Genotype; Hepatitis E; Hepatitis E virus; Humans; Immunocompromised Host; Ribavirin; Treatment Failure	2017
Hepatitis E virus infection. Nature reviews. Disease primers, 2017, Nov-16, Volume: 3 Topics: Animals; Antiviral Agents; Blood Donors; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Humans; Ribavirin; Risk Factors; Zoonoses	2017
Dosing ribavirin in hepatitis E-infected solid organ transplant recipients. Pharmacological research, 2018, Volume: 130 Topics: Animals; Antiviral Agents; Hepatitis E; Humans; Ribavirin; Transplant Recipients	2018
Hepatitis E: Update on Prevention and Control. BioMed research international, 2018, Volume: 2018 Topics: China; Genotype; Hepatitis E; Hepatitis E virus; Humans; Ribavirin; Vaccines, Synthetic	2018
Acute and Persistent Hepatitis E Virus Genotype 3 and 4 Infection: Clinical Features, Pathogenesis, and Treatment. Cold Spring Harbor perspectives in medicine, 2019, 07-01, Volume: 9, Issue:7 Topics: Acute Disease; Age Factors; Animals; Antiviral Agents; Chronic Disease; Disease Transmission, Infectious; Genotype; Hepatitis E; Hepatitis E virus; Humans; Immunocompromised Host; Ribavirin; Sex Factors; Transplant Recipients	2019
Hepatitis E virus treatment and ribavirin therapy: viral mechanisms of nonresponse. Current opinion in virology, 2018, Volume: 32 Topics: Antiviral Agents; Drug Resistance, Multiple, Viral; Genome, Viral; Genotype; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Humans; Interferon-alpha; Open Reading Frames; Polymorphism, Single Nucleotide; Ribavirin; Treatment Failure	2018
[Hepatitis E - an underestimated infectious disease]. MMW Fortschritte der Medizin, 2019, Volume: 161, Issue:3 Topics: Antiviral Agents; Communicable Diseases; Hepatitis E; Humans; Ribavirin	2019
Hepatitis E Virus Drug Development. Viruses, 2019, 05-28, Volume: 11, Issue:6 Topics: Antiviral Agents; Drug Development; Drug Therapy, Combination; Female; Hepatitis E; Humans; Immunocompromised Host; Interferon-alpha; Pregnancy; Ribavirin	2019
The Clinical Perspective on Hepatitis E. Viruses, 2019, 07-05, Volume: 11, Issue:7 Topics: Animals; Antiviral Agents; Chronic Disease; Female; Genotype; Hepatitis E; Hepatitis E virus; Humans; Immunocompromised Host; Pregnancy; Pregnancy Complications, Infectious; Ribavirin	2019
Recent data on hepatitis E. Current opinion in infectious diseases, 2019, Volume: 32, Issue:5 Topics: Antiviral Agents; Disease Reservoirs; Disease Transmission, Infectious; Foodborne Diseases; Global Health; Hepatitis E; Hepatitis E virus; Humans; Prevalence; Ribavirin	2019
Chronic hepatitis E infection: risks and controls. Intervirology, 2013, Volume: 56, Issue:4 Topics: Animals; Communicable Disease Control; Foodborne Diseases; Hepatitis E; Hepatitis, Chronic; Humans; Immunocompromised Host; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors; Zoonoses	2013
Hepatitis E infection in liver transplant recipients. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2014, Volume: 20, Issue:1 Topics: Animals; Chronic Disease; Disease Progression; Feces; Fibrosis; Food Microbiology; Hepatitis E; Humans; Immunosuppression Therapy; Interferons; Liver; Liver Failure; Liver Transplantation; Ribavirin; RNA, Viral	2014
Hepatitis E: when to treat and how to treat. Antiviral therapy, 2014, Volume: 19, Issue:2 Topics: Antiviral Agents; Hepatitis E; Humans; Immunocompromised Host; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2014
Antiviral strategies for hepatitis E virus. Antiviral research, 2014, Volume: 102 Topics: Animals; Antiviral Agents; Drug Discovery; Drug Therapy, Combination; Hepatitis E; Humans; Interferon-alpha; Ribavirin	2014
Hepatitis E in Germany--an under-reported infectious disease. Deutsches Arzteblatt international, 2014, Sep-01, Volume: 111, Issue:35-36 Topics: Adolescent; Aged; Antiviral Agents; Child; Child, Preschool; Female; Germany; Hepatitis E; Humans; Infant; Infant, Newborn; Male; Middle Aged; Prevalence; Research Design; Ribavirin; Risk Factors; Young Adult	2014
[Hepatitis E virus]. Presse medicale (Paris, France : 1983), 2015, Volume: 44, Issue:3 Topics: Algorithms; Animals; Antiviral Agents; Diagnosis, Differential; Disease Models, Animal; Hepatitis E; Hepatitis E virus; Humans; Ribavirin	2015
Antiviral therapy in chronic hepatitis E: a systematic review. Journal of viral hepatitis, 2015, Volume: 22, Issue:12 Topics: Adult; Antiviral Agents; Female; Graft Rejection; Hepatitis E; Hepatitis E virus; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Organ Transplantation; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome	2015
Hepatitis E: an emerging global disease - from discovery towards control and cure. Journal of viral hepatitis, 2016, Volume: 23, Issue:2 Topics: Animals; Antiviral Agents; Hepatitis E; Hepatitis E virus; Humans; Liver; Ribavirin; RNA, Viral; Viral Hepatitis Vaccines; Zoonoses	2016
Hepatitis E, the neglected one. Liver international : official journal of the International Association for the Study of the Liver, 2016, Volume: 36 Suppl 1 Topics: Antiviral Agents; Developing Countries; Feces; Female; Hepatitis Antibodies; Hepatitis E; Hepatitis E virus; Humans; Immunocompromised Host; Immunoglobulin M; Pregnancy; Ribavirin; RNA, Viral	2016
Update on hepatitis E virology: Implications for clinical practice. Journal of hepatology, 2016, Volume: 65, Issue:1 Topics: Animals; Feces; Hepatitis E; Hepatitis E virus; Humans; Open Reading Frames; Ribavirin	2016
Treatment of HEV Infection in Patients with a Solid-Organ Transplant and Chronic Hepatitis. Viruses, 2016, 08-15, Volume: 8, Issue:8 Topics: Hepatitis E; Hepatitis, Chronic; Humans; Interferons; Organ Transplantation; Ribavirin; Transplant Recipients	2016
Treatment of hepatitis E virus. Current opinion in infectious diseases, 2016, Volume: 29, Issue:6 Topics: Animals; Antiviral Agents; Genotype; Hepatitis E; Hepatitis E virus; Humans; Immunocompromised Host; Ribavirin; Swine	2016
Mutagenic Effects of Ribavirin on Hepatitis E Virus-Viral Extinction versus Selection of Fitness-Enhancing Mutations. Viruses, 2016, 10-13, Volume: 8, Issue:10 Topics: Antiviral Agents; Coronaviridae; Drug Resistance, Viral; Hepatitis E; Hepatitis E virus; Humans; Mutagens; Mutation; Ribavirin; Selection, Genetic; Treatment Outcome; Virulence; Viruses	2016
Acute Hepatitis E: Two Sides of the Same Coin. Viruses, 2016, 11-03, Volume: 8, Issue:11 Topics: Animals; Antiviral Agents; Disease Transmission, Infectious; Global Health; Hepatitis E; Humans; Incidence; Ribavirin; Swine; Treatment Outcome; Zoonoses	2016
Current issues in the management of paediatric viral hepatitis. Liver international : official journal of the International Association for the Study of the Liver, 2010, Volume: 30, Issue:1 Topics: Adult; Antiviral Agents; Child; Child, Preschool; Female; Hepatitis A; Hepatitis A Vaccines; Hepatitis A Virus, Human; Hepatitis B; Hepatitis B Vaccines; Hepatitis E; Hepatitis E virus; Hepatitis, Viral, Human; Humans; Interferon alpha-2; Interferon-alpha; Liver Failure, Acute; Polyethylene Glycols; Pregnancy; Recombinant Proteins; Ribavirin; Vaccination; Viral Hepatitis Vaccines	2010

Trials

1 trial(s) available for ribavirin and Hepatitis E

Article	Year
Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience. Liver international : official journal of the International Association for the Study of the Liver, 2013, Volume: 33, Issue:5 Topics: Adult; Cohort Studies; Female; Germany; Hemoglobins; Hepatitis E; Hepatitis E virus; Humans; Immunoglobulin G; Male; Middle Aged; Prospective Studies; Ribavirin; RNA, Viral; Statistics, Nonparametric; Treatment Outcome	2013

Article

Year

Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience.

Liver international : official journal of the International Association for the Study of the Liver, 2013, Volume: 33, Issue:5

Topics: Adult; Cohort Studies; Female; Germany; Hemoglobins; Hepatitis E; Hepatitis E virus; Humans; Immunoglobulin G; Male; Middle Aged; Prospective Studies; Ribavirin; RNA, Viral; Statistics, Nonparametric; Treatment Outcome

2013

Other Studies

147 other study(ies) available for ribavirin and Hepatitis E

Article	Year
Hepatitis E Virus Species C Infection in Humans, Hong Kong. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 08-25, Volume: 75, Issue:2 Topics: Aged; Animals; Hepatitis C; Hepatitis E; Hepatitis E virus; Hong Kong; Humans; Phylogeny; Rats; Ribavirin; RNA, Viral	2022
Modelling of Hepatitis E virus RNA-dependent RNA polymerase genotype 3 from a chronic patient and Journal of biomolecular structure & dynamics, 2023, Volume: 41, Issue:2 Topics: Antiviral Agents; Genotype; Hepatitis E; Hepatitis E virus; Humans; Molecular Docking Simulation; Ribavirin; RNA-Dependent RNA Polymerase	2023
High dose sofosbuvir and sofosbuvir-plus-ribavirin therapy inhibit Hepatitis E Virus (HEV) replication in a rabbit model for acute HEV infection. Antiviral research, 2022, Volume: 199 Topics: Animals; Antiviral Agents; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis E; Hepatitis E virus; Humans; Rabbits; Ribavirin; Sofosbuvir; Treatment Outcome	2022
Persistence of hepatitis E virus in the cerebrospinal fluid despite apparently successful ribavirin therapy. The Journal of antimicrobial chemotherapy, 2022, 07-28, Volume: 77, Issue:8 Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis E; Hepatitis E virus; Humans; Ribavirin; RNA, Viral	2022
Mechanisms of CD8+ T-cell failure in chronic hepatitis E virus infection. Journal of hepatology, 2022, Volume: 77, Issue:4 Topics: CD8-Positive T-Lymphocytes; Epitopes, T-Lymphocyte; Hepatitis E; Hepatitis E virus; Humans; Interferon-gamma; Liver Cirrhosis; Liver Failure; Ribavirin	2022
Hepatitis E case series: A UK experience. Journal of viral hepatitis, 2022, Volume: 29, Issue:9 Topics: Antiviral Agents; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis E; Humans; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; United Kingdom	2022
Identification of structurally re-engineered rocaglates as inhibitors against hepatitis E virus replication. Antiviral research, 2022, Volume: 204 Topics: Antiviral Agents; Hepatitis E; Hepatitis E virus; Humans; Interferon-alpha; Ribavirin; Virus Replication	2022
A Less Common Cause of Acute Hepatitis in Kidney Transplant Recipients: A Case Series. Transplantation proceedings, 2022, Volume: 54, Issue:5 Topics: Acute Disease; Hepatitis E; Hepatitis E virus; Humans; Kidney Transplantation; Ribavirin; Transplant Recipients	2022
Clinical features of hepatitis E infections in patients with hematologic disorders. Haematologica, 2022, 12-01, Volume: 107, Issue:12 Topics: Antiviral Agents; Hematologic Diseases; Hepatitis E; Hepatitis E virus; Humans; Retrospective Studies; Ribavirin; Treatment Outcome	2022
Hepatitis E Diagnosis and Management After Liver, Kidney, or Heart Transplant: A Single-Center Experience. Transplantation proceedings, 2022, Volume: 54, Issue:7 Topics: Acute Disease; Antiviral Agents; Heart Transplantation; Hepatitis E; Hepatitis E virus; Humans; Immunoglobulin M; Kidney; Pancreatitis; Retrospective Studies; Ribavirin; RNA, Viral; Transplant Recipients	2022
Two mutations in the ORF1 of genotype 1 hepatitis E virus enhance virus replication and may associate with fulminant hepatic failure. Proceedings of the National Academy of Sciences of the United States of America, 2022, 08-23, Volume: 119, Issue:34 Topics: Female; Genotype; Hepatitis E; Hepatitis E virus; Humans; Liver Failure, Acute; Mutation; Pregnancy; Ribavirin; Virus Replication	2022
Hepatitis E Virus Infection in Cancer Patients. Transplantation and cellular therapy, 2022, Volume: 28, Issue:11 Topics: Adult; Female; Hematologic Neoplasms; Hepatitis E; Hepatitis E virus; Humans; Male; Neoplasms; Retrospective Studies; Ribavirin; RNA; United States; Viremia	2022
Severe hepatitis E in an immunocompetent young female treated with ribavirin. Revista espanola de enfermedades digestivas, 2023, Volume: 115, Issue:5 Topics: Adult; Female; Hepatitis E; Hepatitis E virus; Humans; Ribavirin; Viremia; Young Adult	2023
Case Report: Chronic hepatitis E in a hematopoietic stem cell transplant recipient: The first report of hepatitis E virus genotype 4 causing chronic infection in a non-solid organ recipient. Frontiers in immunology, 2022, Volume: 13 Topics: Alanine Transaminase; Genotype; Hematopoietic Stem Cell Transplantation; Hepatitis E; Hepatitis E virus; Humans; Immunoglobulin G; Immunoglobulin M; Male; Persistent Infection; Ribavirin; RNA	2022
Unmet Needs for the Treatment of Chronic Hepatitis E Virus Infection in Immunocompromised Patients. Viruses, 2022, 09-25, Volume: 14, Issue:10 Topics: Animals; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Immunocompromised Host; Rats; Ribavirin	2022
Ritonavir Blocks Hepatitis E Virus Internalization and Clears Hepatitis E Virus In Vitro with Ribavirin. Viruses, 2022, 11-03, Volume: 14, Issue:11 Topics: Antiviral Agents; Hepatitis E; Hepatitis E virus; Humans; Ribavirin; Ritonavir; Virus Internalization	2022
Chronic hepatitis E in an elderly immunocompetent patient who achieved a sustained virologic response with ribavirin treatment. Clinical journal of gastroenterology, 2023, Volume: 16, Issue:2 Topics: Adult; Aged; Antiviral Agents; Azathioprine; Female; Hepatitis E; Hepatitis E virus; Hepatitis, Autoimmune; Humans; Prednisolone; Ribavirin; RNA, Viral; Sustained Virologic Response; Young Adult	2023
Quasispecies Fitness Partition to Characterize the Molecular Status of a Viral Population. Negative Effect of Early Ribavirin Discontinuation in a Chronically Infected HEV Patient. International journal of molecular sciences, 2022, Nov-24, Volume: 23, Issue:23 Topics: Follow-Up Studies; Hepatitis E; Hepatitis E virus; Humans; Mutagens; Nucleotides; Quasispecies; Ribavirin; SARS-CoV-2	2022
Diagnostic and management strategies for chronic hepatitis E infection. Expert review of anti-infective therapy, 2023, Volume: 21, Issue:2 Topics: Antiviral Agents; Hepatitis E; Hepatitis E virus; Humans; Immunocompromised Host; Interferons; Persistent Infection; Retrospective Studies; Ribavirin	2023
Immunomodulation of Natural Killer Cell Function by Ribavirin Involves TYK-2 Activation and Subsequent Increased IFN-γ Secretion in the Context of In Vitro Hepatitis E Virus Infection. Cells, 2023, 01-31, Volume: 12, Issue:3 Topics: Carcinoma, Hepatocellular; Hepatitis E; Hepatitis E virus; Humans; Interferon-gamma; Killer Cells, Natural; Liver Neoplasms; Ribavirin	2023
Ribavirin Treatment Failure-Associated Mutation, Y1320H, in the RNA-Dependent RNA Polymerase of Genotype 3 Hepatitis E Virus (HEV) Enhances Virus Replication in a Rabbit HEV Infection Model. mBio, 2023, 04-25, Volume: 14, Issue:2 Topics: Animals; Antiviral Agents; Genotype; Hepatitis E; Hepatitis E virus; Humans; Mutation; Rabbits; Ribavirin; RNA-Dependent RNA Polymerase; RNA, Viral; Treatment Failure; Virus Replication	2023
Treatment of Hepatitis E. Advances in experimental medicine and biology, 2023, Volume: 1417 Topics: Female; Hepatitis E; Humans; Liver Failure; Liver Transplantation; Pregnancy; Ribavirin	2023
Variable Outcomes of Hepatitis E Infections in Patients with Hemato-Oncologic Diseases. Oncology research and treatment, 2023, Volume: 46, Issue:7-8 Topics: Antiviral Agents; Hepatitis E; Hepatitis E virus; Humans; Liver Failure; Retrospective Studies; Ribavirin	2023
Establishment of a robust rat hepatitis E virus fecal-oral infection model and validation for antiviral studies. Antiviral research, 2023, Volume: 216 Topics: Animals; Antiviral Agents; Feces; Hepatitis E; Hepatitis E virus; Humans; Rats; Ribavirin; RNA, Viral	2023
Whole genome sequencing reveals insights into hepatitis E virus genome diversity, and virus compartmentalization in chronic hepatitis E. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2023, Volume: 168 Topics: Animals; Antiviral Agents; Genotype; Hepatitis E; Hepatitis E virus; Humans; Persistent Infection; Ribavirin; Whole Genome Sequencing	2023
Acute liver failure in immunocompetent patients infected with hepatitis E. Wiener klinische Wochenschrift, 2019, Volume: 131, Issue:17-18 Topics: Aged; Hepatitis E; Hepatitis E virus; Humans; Immunocompromised Host; Liver Failure, Acute; Male; Ribavirin	2019
Chronic hepatitis E infection in an immunosuppressed, solid organ transplant patient. Internal medicine journal, 2019, Volume: 49, Issue:10 Topics: Fatal Outcome; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Organ Transplantation; Ribavirin	2019
Early Detection of Hepatitis E Virus Ribavirin Resistance Using Next-Generation Sequencing. Antimicrobial agents and chemotherapy, 2019, 12-20, Volume: 64, Issue:1 Topics: Antiviral Agents; Hepatitis E; Hepatitis E virus; High-Throughput Nucleotide Sequencing; Humans; Mutation; Ribavirin	2019
Therapy for Chronic Hepatitis E Virus Infection-Current Recommendations and Future Aspirations. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 08-22, Volume: 71, Issue:5 Topics: Antiviral Agents; Hepatitis E; Hepatitis E virus; Humans; Organ Transplantation; Retrospective Studies; Ribavirin	2020
Ribavirin for Hepatitis E Virus Infection After Organ Transplantation: A Large European Retrospective Multicenter Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 08-22, Volume: 71, Issue:5 Topics: Antiviral Agents; Hepatitis E; Hepatitis E virus; Humans; Organ Transplantation; Retrospective Studies; Ribavirin; RNA, Viral	2020
The challenge of chronic hepatitis E in liver transplant recipients: Failure of sofosbuvir plus ribavirin therapy. Gastroenterologia y hepatologia, 2020, Volume: 43, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Burkitt Lymphoma; Common Variable Immunodeficiency; Drug Therapy, Combination; Fatal Outcome; Focal Nodular Hyperplasia; Hepatitis E; Hepatitis E virus; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Kidney Transplantation; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Ribavirin; RNA, Viral; Sofosbuvir	2020
Mortality and morbidity of locally acquired hepatitis E in the national Scottish cohort: a multicentre retrospective study. Alimentary pharmacology & therapeutics, 2020, Volume: 51, Issue:10 Topics: Acute-On-Chronic Liver Failure; Adult; Aged; Aged, 80 and over; Female; Hepatitis E; Humans; Immunocompromised Host; Liver Cirrhosis; Male; Middle Aged; Retrospective Studies; Ribavirin; Scotland	2020
Ribavirin long-term treatment for chronic hepatitis E virus infection in a liver transplant recipient. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2020, Volume: 52, Issue:8 Topics: Aged; Antiviral Agents; Dose-Response Relationship, Drug; Hepatitis E; Hepatitis, Chronic; Humans; Immunosuppressive Agents; Liver Transplantation; Off-Label Use; Ribavirin; Transplant Recipients	2020
Persistent infection with a rabbit hepatitis E virus created by a reverse genetics system. Transboundary and emerging diseases, 2021, Volume: 68, Issue:2 Topics: Animals; Antiviral Agents; Genome-Wide Association Study; Genome, Viral; Hepatitis E; Hepatitis E virus; Rabbits; Reverse Genetics; Ribavirin; Virus Replication	2021
Pegylated interferon may be considered in chronic viral hepatitis E resistant to ribavirin in kidney transplant recipients. BMC infectious diseases, 2020, Jul-16, Volume: 20, Issue:1 Topics: Drug Resistance, Viral; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Humans; Interferon-alpha; Kidney Transplantation; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Remission Induction; Ribavirin; Sustained Virologic Response; Transplant Recipients; Treatment Outcome	2020
Determining the therapeutic range for ribavirin in transplant recipients with chronic hepatitis E virus infection. Journal of viral hepatitis, 2021, Volume: 28, Issue:2 Topics: Adult; Antiviral Agents; Cohort Studies; Drug Therapy, Combination; Hepatitis E; Hepatitis E virus; Humans; Retrospective Studies; Ribavirin; Transplant Recipients	2021
Drug screening identified gemcitabine inhibiting hepatitis E virus by inducing interferon-like response via activation of STAT1 phosphorylation. Antiviral research, 2020, Volume: 184 Topics: Antiviral Agents; Cell Line; Deoxycytidine; Drug Evaluation, Preclinical; Drug Repositioning; Drug Synergism; Gemcitabine; Gene Expression Regulation; Hepatitis E; Hepatitis E virus; Host Microbial Interactions; Humans; Interferon-alpha; Janus Kinases; Mycophenolic Acid; Phosphorylation; Pyrimidine Nucleosides; Response Elements; Ribavirin; Signal Transduction; STAT1 Transcription Factor; Virus Replication	2020
Practical considerations when treating chronic hepatitis E in solid organ transplant recipients. International journal of clinical pharmacy, 2021, Volume: 43, Issue:3 Topics: Antiviral Agents; Hepatitis E; Hepatitis E virus; Humans; Organ Transplantation; Ribavirin	2021
Ribavirin monotherapy for the treatment of chronic hepatitis E in an immunosuppressed patient. Revista espanola de enfermedades digestivas, 2021, Volume: 113, Issue:5 Topics: Antiviral Agents; Hepatitis E; HIV Infections; Humans; Immunocompromised Host; Liver Cirrhosis; Male; Middle Aged; Ribavirin	2021
Recurrent Chronic HEV in Severe Combined Immunodeficiency. Journal of clinical immunology, 2021, Volume: 41, Issue:5 Topics: Adult; Antibodies, Viral; Antiviral Agents; Chronic Disease; Female; Hepatitis E; Hepatitis E virus; Humans; Immunoglobulin G; Immunoglobulin M; Janus Kinase 3; Recurrence; Ribavirin; RNA, Viral; Severe Combined Immunodeficiency; T-Lymphocytes	2021
Hepatitis E, what is the real issue? Liver international : official journal of the International Association for the Study of the Liver, 2021, Volume: 41 Suppl 1 Topics: China; Female; Hepatitis Antibodies; Hepatitis E; Hepatitis E virus; Humans; Pregnancy; Ribavirin	2021
Generation of a Bactrian camel hepatitis E virus by a reverse genetics system. The Journal of general virology, 2021, Volume: 102, Issue:7 Topics: Amides; Animals; Antiviral Agents; Capsid Proteins; Cell Line; Female; Genome, Viral; Hepatitis E; Hepatitis E virus; Humans; Macaca fascicularis; Male; Mice; Mice, Nude; Pyrazines; Rats; Reverse Genetics; Ribavirin; RNA, Viral; Transfection; Virus Replication	2021
First confirmed case of transfusion-transmitted hepatitis E in Australia. The Medical journal of Australia, 2017, 04-17, Volume: 206, Issue:7 Topics: Antiviral Agents; Australia; Blood Transfusion; Child; Cross Infection; Hepatitis E; Hepatitis E virus; Humans; Liver Transplantation; Male; Plasma; Ribavirin; RNA, Viral	2017
Chronic hepatitis E in HIV/HBV coinfected patient: lack of power of sofosbuvir-ribavirin. AIDS (London, England), 2017, 06-01, Volume: 31, Issue:9 Topics: Alanine Transaminase; Antiviral Agents; Coinfection; Hepatitis B; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; HIV Infections; Humans; Male; Middle Aged; Ribavirin; Sofosbuvir; Treatment Failure; Viral Load	2017
[Hepatitis E - More than a Rare Travel-Associated Infectious Disease!] Deutsche medizinische Wochenschrift (1946), 2017, Volume: 142, Issue:11 Topics: Antiviral Agents; Germany; Hepatitis E; Humans; Ribavirin; Risk Factors; Travel	2017
Chronic hepatitis in the transplant patient. British journal of hospital medicine (London, England : 2005), 2017, Jul-02, Volume: 78, Issue:7 Topics: Aged; Alanine Transaminase; Antiviral Agents; Graft Rejection; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Humans; Immunocompromised Host; Immunoglobulin M; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Polycystic Kidney Diseases; Polymerase Chain Reaction; Ribavirin; RNA, Viral; Tacrolimus; Viral Load	2017
Ribavirin treatment of a patient with chronic hepatitis E.\ First case reported in Latin America. Acta gastroenterologica Latinoamericana, 2016, Volume: 46, Issue:2 Topics: Adult; Antiviral Agents; Biomarkers; Chronic Disease; Hepatitis Antibodies; Hepatitis E; Hepatitis E virus; Humans; Kidney Transplantation; Male; Ribavirin	2016
Summary of the British Transplantation Society UK Guidelines for Hepatitis E and Solid Organ Transplantation. Transplantation, 2018, Volume: 102, Issue:1 Topics: Hepatitis E; Humans; Organ Transplantation; Practice Guidelines as Topic; Ribavirin; Societies, Medical; United Kingdom	2018
Chronic hepatitis E virus infection in a cirrhotic patient: A case report. Medicine, 2017, Volume: 96, Issue:39 Topics: Antiviral Agents; Enzyme-Linked Immunospot Assay; Hepatitis E; Hepatitis, Chronic; Humans; Interferon-gamma; Liver Cirrhosis; Male; Middle Aged; Ribavirin	2017
Transfusion-acquired hepatitis E infection misdiagnosed as severe critical illness polyneuromyopathy in a heart transplant patient. Transplant infectious disease : an official journal of the Transplantation Society, 2017, Volume: 19, Issue:6 Topics: Antiviral Agents; Blood Transfusion; Critical Illness; Diagnostic Errors; Fatal Outcome; Heart Transplantation; Hepatitis E; Hepatitis E virus; Humans; Male; Middle Aged; Multiple Organ Failure; Muscular Diseases; Polyneuropathies; Polyradiculoneuropathy; Postoperative Period; Ribavirin; RNA, Viral	2017
Genotype 4 hepatitis E virus is a cause of chronic hepatitis in renal transplant recipients in Hong Kong. Journal of viral hepatitis, 2018, Volume: 25, Issue:2 Topics: Aged; Antibodies, Viral; Antiviral Agents; Genotype; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Hong Kong; Humans; Immunocompromised Host; Immunoglobulin M; Kidney Transplantation; Male; Middle Aged; Mutation; Retrospective Studies; Ribavirin; Transplant Recipients; Viral Load	2018
Treating chronic hepatitis E: when is enough enough? BMJ case reports, 2018, Feb-01, Volume: 2018 Topics: Adult; Alanine Transaminase; Antiviral Agents; Feces; Hepatitis E; Hepatitis, Chronic; Humans; Immunocompromised Host; Kidney Transplantation; Male; Opportunistic Infections; Ribavirin; Treatment Outcome; Viral Load; Virus Shedding	2018
Chronic Hepatitis E in a Renal Transplant Recipient: The First Report of Genotype 4 Hepatitis E Virus Caused Chronic Infection in Organ Recipient. Gastroenterology, 2018, Volume: 154, Issue:4 Topics: Adult; Antiviral Agents; Genotype; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Phenotype; Ribavirin; Treatment Outcome	2018
Chronic hepatitis E in a heart transplant patient: sofosbuvir and ribavirin regimen not fully effective. Antiviral therapy, 2018, Volume: 23, Issue:5 Topics: Antiviral Agents; Cardiomyopathy, Dilated; Chronic Disease; Drug Therapy, Combination; Heart Transplantation; Hepatitis E; Hepatitis E virus; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Ribavirin; Sofosbuvir; Treatment Failure	2018
Ribavirin therapy of hepatitis E infection may cause hyporegenerative anemia in pediatric renal transplant patients. Pediatric transplantation, 2018, Volume: 22, Issue:4 Topics: Adolescent; Anemia; Antiviral Agents; Chronic Disease; Female; Hepatitis E; Humans; Kidney Transplantation; Postoperative Complications; Ribavirin	2018
Treatment with ribavirin of acute hepatitis and severe renal damage in an immunocompetent patient. Gastroenterologia y hepatologia, 2019, Volume: 42, Issue:2 Topics: Acute Disease; Aged; Antiviral Agents; Hepatitis E; Humans; Kidney Diseases; Male; Ribavirin; Severity of Illness Index	2019
Hepatitis E virus-associated cryoglobulinemia in solid-organ-transplant recipients. Liver international : official journal of the International Association for the Study of the Liver, 2018, Volume: 38, Issue:12 Topics: Adult; Antiviral Agents; Cryoglobulinemia; Female; France; Hepatitis E; Humans; Immunocompromised Host; Kidney; Logistic Models; Male; Middle Aged; Multivariate Analysis; Ribavirin; Transplant Recipients	2018
Hepatitis E-induced acute-on-chronic liver failure and VI nerve paralysis. Liver international : official journal of the International Association for the Study of the Liver, 2018, Volume: 38, Issue:9 Topics: Abducens Nerve Diseases; Acute-On-Chronic Liver Failure; Aged; Antiviral Agents; Hepatitis E; Hepatitis E virus; Humans; Male; Ribavirin	2018
Autochthonous acute hepatitis E: treatment with sofosbuvir and ribavirin. Infection, 2018, Volume: 46, Issue:5 Topics: Acute-On-Chronic Liver Failure; Biomarkers; Coinfection; Drug Therapy, Combination; Fatal Outcome; Hepatitis E; Humans; Liver Function Tests; Male; Middle Aged; Ribavirin; Shock, Septic; Sofosbuvir; Treatment Outcome; Viral Load	2018
The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo. Antiviral research, 2018, Volume: 157 Topics: Aglaia; Animals; Antiviral Agents; Cells, Cultured; Disease Models, Animal; Drug Interactions; Feces; Hepatitis E; Hepatitis E virus; Humans; Mice; Ribavirin; Triterpenes; Viral Load; Virus Replication	2018
Thrombotic thrombocytopenic purpura relapse induced by acute hepatitis E transmitted by cryosupernatant plasma and successfully controlled with ribavirin. Transfusion, 2018, Volume: 58, Issue:11 Topics: Antiviral Agents; Hepatitis E; Humans; Male; Methylene Blue; Middle Aged; Phylogeny; Plasma; Purpura, Thrombotic Thrombocytopenic; Ribavirin	2018
Sofosbuvir and Ribavirin Eradication of Refractory Hepatitis E in an Immunosuppressed Kidney Transplant Recipient. Hepatology (Baltimore, Md.), 2019, Volume: 69, Issue:5 Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis E; Humans; Immunosuppression Therapy; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Ribavirin; Sofosbuvir	2019
Monitoring hepatitis E virus fecal shedding to optimize ribavirin treatment duration in chronically infected transplant patients. Journal of hepatology, 2019, Volume: 70, Issue:1 Topics: Aged; Antiviral Agents; Chronic Disease; Duration of Therapy; Feces; Female; Genotype; Hepatitis E; Hepatitis E virus; Humans; Male; Middle Aged; Organ Transplantation; Ribavirin; RNA, Viral	2019
Successful treatment with ribavirine for chronic hepatitis E in chronic lymphocytic leukemia treated with Ibrutinib. Bulletin du cancer, 2019, Volume: 106, Issue:1 Topics: Adenine; Aged; Alemtuzumab; Antineoplastic Agents, Immunological; Antiviral Agents; Chronic Disease; Disease Progression; Hepatitis E; Hepatitis E virus; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Piperidines; Pyrazoles; Pyrimidines; Ribavirin	2019
Failure to respond to ribavirin despite elevated intra-erythrocyte zinc level in transplant-patients with chronic hepatitis E virus infection. Transplant infectious disease : an official journal of the Transplantation Society, 2019, Volume: 21, Issue:2 Topics: Antiviral Agents; Chronic Disease; Erythrocytes; Female; Hepatitis E; Hepatitis E virus; Humans; Immunocompromised Host; Middle Aged; Ribavirin; RNA, Viral; Transplant Recipients; Treatment Failure; Zinc	2019
No Clear Evidence for an Effect of Sofosbuvir Against Hepatitis E Virus in Organ Transplant Patients. Hepatology (Baltimore, Md.), 2019, Volume: 69, Issue:4 Topics: Antiviral Agents; Hepatitis E; Hepatitis E virus; Humans; Kidney Transplantation; Ribavirin; Sofosbuvir	2019
Reply. Hepatology (Baltimore, Md.), 2019, Volume: 69, Issue:4 Topics: Hepatitis E; Humans; Kidney Transplantation; Ribavirin; Sofosbuvir	2019
[Hepatitis E virus infection]. La Revue du praticien, 2018, Volume: 68, Issue:3 Topics: Animals; Europe; Hepatitis E; Hepatitis E virus; Humans; Immunocompromised Host; Ribavirin; Swine	2018
Hepatitis E Virus Infection in Lung Transplant Recipients: A Case Series. Transplantation proceedings, 2019, Volume: 51, Issue:2 Topics: Aged; Antiviral Agents; Enzyme-Linked Immunosorbent Assay; Female; Hepatitis E; Hepatitis E virus; Humans; Immunocompromised Host; Lung Transplantation; Male; Middle Aged; Prospective Studies; Ribavirin; Transplant Recipients	2019
Prevalence of active hepatitis E virus infection and efficacy of ribavirin treatment in renal allograft recipients. Transplant infectious disease : an official journal of the Transplantation Society, 2019, Volume: 21, Issue:3 Topics: Adult; Aged; Allografts; Antiviral Agents; Female; Genotype; Hepatitis Antibodies; Hepatitis E; Hepatitis E virus; Humans; Immunocompromised Host; Kidney Transplantation; Male; Middle Aged; Phylogeny; Prevalence; Ribavirin; RNA, Viral; Transplantation, Homologous; Young Adult	2019
No evidence of occult hepatitis C or E virus infections in liver-transplant patients with sustained virological response after therapy with direct acting agents. Transplant infectious disease : an official journal of the Transplantation Society, 2019, Volume: 21, Issue:4 Topics: Adult; Antiviral Agents; Female; Hepatitis C; Hepatitis E; Humans; Liver; Liver Transplantation; Male; Middle Aged; Ribavirin; RNA, Viral; Sustained Virologic Response; Transplant Recipients	2019
Hepatitis E Virus (HEV) Open Reading Frame 2 Antigen Kinetics in Human-Liver Chimeric Mice and Its Impact on HEV Diagnosis. The Journal of infectious diseases, 2019, 07-31, Volume: 220, Issue:5 Topics: Animals; Disease Models, Animal; Feces; Hepatitis Antigens; Hepatitis E; Hepatitis E virus; Humans; Kinetics; Liver; Mice; Mice, SCID; Ribavirin; RNA, Viral; Viral Proteins	2019
Combination therapy of sofosbuvir and ribavirin fails to clear chronic hepatitis E infection in a multivisceral transplanted patient. Journal of hepatology, 2019, Volume: 71, Issue:1 Topics: Adult; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis E; Hepatitis E virus; Humans; Immunosuppressive Agents; Male; Multiple Organ Failure; Organ Transplantation; Ribavirin; Sofosbuvir; Treatment Failure	2019
The burden of hepatitis E among patients with haematological malignancies: A retrospective European cohort study. Journal of hepatology, 2019, Volume: 71, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Immunological; Antiviral Agents; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Humans; Immunocompromised Host; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Male; Middle Aged; Retrospective Studies; Ribavirin; Rituximab; RNA, Viral; Survival Rate; Young Adult	2019
No link between male infertility and HEV genotype 3 infection. Gut, 2020, Volume: 69, Issue:6 Topics: Genotype; Hepatitis E; Hepatitis E virus; Humans; Infertility, Male; Male; Mutagenesis; Ribavirin	2020
Sofosbuvir add-on to ribavirin for chronic hepatitis E in a cirrhotic liver transplant recipient: a case report. BMC gastroenterology, 2019, May-24, Volume: 19, Issue:1 Topics: Antiviral Agents; Chronic Disease; Drug Therapy, Combination; Hepatitis E; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Postoperative Period; Ribavirin; Sofosbuvir	2019
Successful treatment of HBV, HCV, & HEV, with 12-week long use of tenofovir, sofosbuvir, daclatasvir, and ribavirin: A case report. Journal of infection and public health, 2020, Volume: 13, Issue:1 Topics: Aged; Antiviral Agents; Asthma; Carbamates; Coinfection; Diabetes Complications; Drug Administration Schedule; Drug Therapy, Combination; Hepatitis B; Hepatitis C, Chronic; Hepatitis E; Humans; Imidazoles; Male; Pyrrolidines; Ribavirin; Sofosbuvir; Tenofovir; Treatment Outcome; Valine; Viral Load	2020
Hepatitis E and Allogeneic Hematopoietic Stem Cell Transplantation: A French Nationwide SFGM-TC Retrospective Study. Viruses, 2019, 07-05, Volume: 11, Issue:7 Topics: Adult; Aged; Female; France; Hematopoietic Stem Cell Transplantation; Hepatitis E; Hepatitis E virus; Humans; Immunosuppressive Agents; Liver; Male; Middle Aged; Retrospective Studies; Ribavirin; Treatment Outcome; Young Adult	2019
Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin. Viruses, 2019, 07-09, Volume: 11, Issue:7 Topics: Adult; Aged; Antiviral Agents; Female; Genotype; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Humans; Immunocompromised Host; Kinetics; Male; Middle Aged; Organ Transplantation; Plasma; Ribavirin; RNA, Viral; Sustained Virologic Response; Transplant Recipients; Treatment Failure; Virus Replication	2019
Chronic hepatitis E after kidney transplantation with an antibody response suggestive of reinfection: a case report. BMC infectious diseases, 2019, Jul-30, Volume: 19, Issue:1 Topics: Antibody Formation; Antiviral Agents; Enzyme-Linked Immunosorbent Assay; Hepatitis Antibodies; Hepatitis E; Hepatitis, Chronic; Humans; Immunocompromised Host; Immunoglobulin G; Kidney Transplantation; Male; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Viral	2019
Chronic hepatitis E resolution in a human immunodeficiency virus (HIV)-infected patient treated with ribavirin. International journal of antimicrobial agents, 2013, Volume: 41, Issue:6 Topics: Alanine Transaminase; Antiviral Agents; CD4 Lymphocyte Count; Hepatitis E; Hepatitis, Chronic; HIV Infections; Humans; Male; Middle Aged; Ribavirin; RNA, Viral; Treatment Outcome; Viral Load	2013
Results of single-center screening for chronic hepatitis E in children after liver transplantation and report on successful treatment with ribavirin. Pediatric transplantation, 2013, Volume: 17, Issue:4 Topics: Adolescent; Antibodies, Viral; Antiviral Agents; Child; Child, Preschool; Cohort Studies; Female; Hepatitis; Hepatitis E; Humans; Immunoglobulin G; Immunosuppressive Agents; Infant; Liver Failure; Liver Transplantation; Male; Polymerase Chain Reaction; Postoperative Complications; Retrospective Studies; Ribavirin; RNA, Viral	2013
Chronic hepatitis E in HIV patients: rapid progression to cirrhosis and response to oral ribavirin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 57, Issue:3 Topics: Antiviral Agents; Hepatitis E; Hepatitis, Chronic; HIV Infections; Humans; Liver Cirrhosis; Male; Middle Aged; Ribavirin; Treatment Outcome	2013
Course and treatment of chronic hepatitis E virus infection in lung transplant recipients. Transplant infectious disease : an official journal of the Transplantation Society, 2014, Volume: 16, Issue:2 Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; Chronic Disease; Female; Hepatitis E; Hepatitis E virus; Humans; Immunoglobulin G; Lung Transplantation; Male; Middle Aged; Retrospective Studies; Ribavirin; RNA, Viral; Seroepidemiologic Studies; Virus Replication; Young Adult	2014
Long-term hepatitis E viral load kinetics in an immunocompromised patient treated with ribavirin. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2014, Volume: 20, Issue:10 Topics: Alemtuzumab; Antibodies, Monoclonal, Humanized; Antiviral Agents; Diarrhea; Drug Therapy, Combination; Feces; Female; Hepatitis E; Hepatitis E virus; Humans; Immunocompromised Host; Middle Aged; Prospective Studies; Retrospective Studies; Ribavirin; Treatment Outcome; Viral Load	2014
Chronic hepatitis E virus infection: challenges in diagnosis and recognition in the United States. Journal of clinical gastroenterology, 2015, Volume: 49, Issue:1 Topics: Adult; Antibodies, Viral; Chronic Disease; Hepatitis E; Hepatitis E virus; Humans; Immunoglobulin G; Immunoglobulin M; Kidney Transplantation; Male; Ribavirin; RNA, Viral; United States	2015
Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus. Gastroenterology, 2014, Volume: 146, Issue:7 Topics: Antiviral Agents; Calcineurin; Calcineurin Inhibitors; Cell Line, Tumor; Cyclophilin A; Cyclophilins; Cyclosporine; Dose-Response Relationship, Drug; HEK293 Cells; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Humans; Immunosuppressive Agents; Mycophenolic Acid; Ribavirin; RNA Interference; RNA, Viral; Time Factors; Transfection; Virus Replication	2014
Pregnant woman saved with liver transplantation from acute liver failure due to hepatitis E virus. Transplant international : official journal of the European Society for Organ Transplantation, 2014, Volume: 27, Issue:9 Topics: Acetylcysteine; Acute Disease; Adult; Antibodies, Viral; Antiviral Agents; Asia, Southeastern; Cesarean Section; Combined Modality Therapy; Emergencies; Female; Hepatitis E; Hepatitis E virus; Humans; Immunity, Maternally-Acquired; Immunoglobulin G; Immunoglobulin M; Infant, Newborn; Liver Failure; Liver Transplantation; Plasma; Pregnancy; Pregnancy Complications, Infectious; Ribavirin	2014
Phylogenetic demonstration of hepatitis E infection transmitted by pork meat ingestion. Journal of clinical gastroenterology, 2015, Volume: 49, Issue:2 Topics: Acute Disease; Aged; Animals; Antiviral Agents; Biomarkers; Food Microbiology; Genotype; Hepatitis Antibodies; Hepatitis E; Hepatitis E virus; Humans; Immunocompromised Host; Male; Meat; Phylogeny; Ribavirin; Risk Factors; RNA, Viral; Swine; Treatment Outcome; Zoonoses	2015
Ribavirin for chronic hepatitis E virus infection in transplant recipients. The New England journal of medicine, 2014, Mar-20, Volume: 370, Issue:12 Topics: Adult; Aged; Antiviral Agents; Chronic Disease; Drug Administration Schedule; Female; Hepatitis E; Hepatitis E virus; Humans; Male; Middle Aged; Organ Transplantation; Retrospective Studies; Ribavirin; Viral Load; Virus Replication	2014
A case for ribavirin to treat chronic hepatitis E. The New England journal of medicine, 2014, Mar-20, Volume: 370, Issue:12 Topics: Antiviral Agents; Female; Hepatitis E; Humans; Male; Organ Transplantation; Ribavirin	2014
Successful Treatment of Chronic Hepatitis E After an Orthotopic Liver Transplant With Ribavirin Monotherapy. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2015, Volume: 13, Issue:3 Topics: Antiviral Agents; Biopsy; Hepatitis E; Hepatitis, Chronic; Humans; Immunocompromised Host; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Opportunistic Infections; Ribavirin; Time Factors; Treatment Outcome; Viral Load	2015
Hepatitis E-associated encephalopathy in a renal transplant recipient. BMJ case reports, 2014, Apr-30, Volume: 2014 Topics: Aged; Biopsy, Needle; Chronic Disease; Disease Progression; Electromyography; Female; Follow-Up Studies; Graft Survival; Hepatic Encephalopathy; Hepatitis E; Humans; Immunocompromised Host; Immunohistochemistry; Kidney Failure, Chronic; Kidney Transplantation; Liver Function Tests; Magnetic Resonance Imaging; Ribavirin; Severity of Illness Index; Transplant Recipients; Transplantation Immunology; Treatment Outcome; Viral Load	2014
Severe acute hepatitis E in an HIV infected patient: Successful treatment with ribavirin. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2014, Volume: 60, Issue:4 Topics: Adult; Alanine Transaminase; Bilirubin; CD4 Lymphocyte Count; Hepatitis Antibodies; Hepatitis E; HIV Infections; Humans; Immunocompromised Host; Liver Function Tests; Male; Prothrombin Time; Ribavirin; RNA, Viral; Viral Load	2014
Older men with unexplained hepatitis. BMJ case reports, 2014, Jun-05, Volume: 2014 Topics: Antiviral Agents; Hepatitis E; Humans; Jaundice; Liver; Male; Middle Aged; Ribavirin	2014
Ribavirin for chronic hepatitis E virus infection. The New England journal of medicine, 2014, 06-19, Volume: 370, Issue:25 Topics: Antiviral Agents; Female; Hepatitis E; Humans; Male; Organ Transplantation; Ribavirin	2014
Ribavirin for chronic hepatitis E virus infection. The New England journal of medicine, 2014, 06-19, Volume: 370, Issue:25 Topics: Antiviral Agents; Female; Hepatitis E; Humans; Male; Organ Transplantation; Ribavirin	2014
Ribavirin for chronic hepatitis E virus infection. The New England journal of medicine, 2014, 06-19, Volume: 370, Issue:25 Topics: Antiviral Agents; Female; Hepatitis E; Humans; Male; Organ Transplantation; Ribavirin	2014
Ribavirin for chronic hepatitis E virus infection. The New England journal of medicine, 2014, 06-19, Volume: 370, Issue:25 Topics: Antiviral Agents; Female; Hepatitis E; Humans; Male; Organ Transplantation; Ribavirin	2014
A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients. Gastroenterology, 2014, Volume: 147, Issue:5 Topics: Antiviral Agents; DNA-Directed RNA Polymerases; Dose-Response Relationship, Drug; Drug Resistance, Viral; Female; Genotype; Hep G2 Cells; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Humans; Male; Mutagenesis, Site-Directed; Mutation; Organ Transplantation; Phenotype; Ribavirin; Time Factors; Transfection; Treatment Failure; Virus Replication	2014
Protracted fecal shedding of HEV during ribavirin therapy predicts treatment relapse. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Jan-01, Volume: 60, Issue:1 Topics: Adult; Aged; Antiviral Agents; Feces; Female; Hepatitis E; Hepatitis E virus; Humans; Male; Middle Aged; Organ Transplantation; Recurrence; Ribavirin; Treatment Outcome; Virus Shedding	2015
HEV infection in two referral centers in Spain: epidemiology and clinical outcomes. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2015, Volume: 63 Topics: Adult; Aged; Antiviral Agents; Female; Hepatitis E; Humans; Male; Middle Aged; Organ Transplantation; Ribavirin; Spain; Travel; Treatment Outcome	2015
Successful treatment of hepatitis E virus-associated cryoglobulinemic membranoproliferative glomerulonephritis with ribavirin. Transplant infectious disease : an official journal of the Transplantation Society, 2015, Volume: 17, Issue:2 Topics: Antiviral Agents; Cryoglobulinemia; Glomerulonephritis, Membranoproliferative; Graft Rejection; Hepatitis E; Hepatitis E virus; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Nephritis, Hereditary; Ribavirin; Transplant Recipients; Treatment Outcome	2015
Domestically acquired hepatitis E successfully treated with ribavirin in an Australian liver transplant recipient. The Medical journal of Australia, 2015, Mar-02, Volume: 202, Issue:4 Topics: Antibodies, Viral; Antiviral Agents; Australia; End Stage Liver Disease; Follow-Up Studies; Hepatitis E; Hepatitis E virus; Humans; Liver Transplantation; Male; Middle Aged; Ribavirin; RNA, Viral; Transplant Recipients	2015
Treatment with ribavirin of hepatitis E virus chronic infection in transplanted patients. Revista espanola de enfermedades digestivas, 2015, Volume: 107, Issue:3 Topics: Antiviral Agents; Hepatitis E; Humans; Liver; Liver Transplantation; Male; Middle Aged; Ribavirin	2015
Outcome of hepatitis E virus infection in patients with inflammatory arthritides treated with immunosuppressants: a French retrospective multicenter study. Medicine, 2015, Volume: 94, Issue:14 Topics: Adult; Aged; Antiviral Agents; Arthritis; Female; France; Hepatitis E; Humans; Immunosuppressive Agents; Male; Middle Aged; Retrospective Studies; Ribavirin; Treatment Outcome	2015
Current data. Deutsches Arzteblatt international, 2015, Mar-27, Volume: 112, Issue:13 Topics: Female; Hepatitis E; Humans; Male; Research Design; Ribavirin	2015
In reply. Deutsches Arzteblatt international, 2015, Mar-27, Volume: 112, Issue:13 Topics: Female; Hepatitis E; Humans; Male; Research Design; Ribavirin	2015
Relevance of chronic hepatitis E in liver transplant recipients: a real-life setting. Transplant infectious disease : an official journal of the Transplantation Society, 2015, Volume: 17, Issue:4 Topics: Adolescent; Adult; Aged; Antiviral Agents; Female; Hepatitis E; Hepatitis, Chronic; Humans; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Prospective Studies; Ribavirin; Treatment Outcome; Young Adult	2015
Treatment of autochthonous acute hepatitis E with short-term ribavirin: a multicenter retrospective study. Liver international : official journal of the International Association for the Study of the Liver, 2016, Volume: 36, Issue:3 Topics: Acute Disease; Aged; Aged, 80 and over; Antiviral Agents; Drug Administration Schedule; Female; France; Genotype; Hepatitis E; Hepatitis E virus; Humans; Immunocompromised Host; Male; Middle Aged; Opportunistic Infections; Recurrence; Remission Induction; Ribavirin; RNA, Viral; Severity of Illness Index; Time Factors; Treatment Outcome; Viral Load	2016
Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies. Emerging infectious diseases, 2015, Volume: 21, Issue:8 Topics: Antiviral Agents; Hematologic Neoplasms; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Humans; Ribavirin	2015
An Early Viral Response Predicts the Virological Response to Ribavirin in Hepatitis E Virus Organ Transplant Patients. Transplantation, 2015, Volume: 99, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Calcineurin Inhibitors; Child; Female; Hepatitis E; Humans; Immunosuppressive Agents; Male; Middle Aged; Organ Transplantation; Predictive Value of Tests; Ribavirin; RNA, Viral; Virus Replication; Young Adult	2015
Taming the Beast: Tailored Therapy for Hepatitis E in Organ Transplant Recipients. Transplantation, 2015, Volume: 99, Issue:10 Topics: Female; Hepatitis E; Humans; Male; Organ Transplantation; Ribavirin	2015
First Case Genotype 4 Hepatitis E Infection After a Liver Transplant. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2017, Volume: 15, Issue:2 Topics: Antiviral Agents; Biopsy; Fatal Outcome; Female; Genotype; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Humans; Liver Function Tests; Liver Transplantation; Middle Aged; Phenotype; Predictive Value of Tests; Ribavirin; RNA, Viral; Treatment Outcome	2017
Chronic hepatitis E infection with an emerging virus strain in a heart transplant recipient successfully treated with ribavirin: a case report. Journal of medical case reports, 2015, Aug-26, Volume: 9 Topics: Antiviral Agents; Chronic Disease; Heart Transplantation; Hepatitis E; Humans; Immunocompromised Host; Male; Middle Aged; Polymerase Chain Reaction; Ribavirin	2015
Hepatitis E infection in patients with severe alcoholic hepatitis: is there a place for systematic screening? European journal of gastroenterology & hepatology, 2015, Volume: 27, Issue:12 Topics: Acute Disease; Adult; Aged; Antibodies, Viral; Antiviral Agents; Female; Glucocorticoids; Hepatitis E; Hepatitis E virus; Hepatitis, Alcoholic; Hospitalization; Humans; Immunoglobulin G; Immunoglobulin M; Male; Mass Screening; Middle Aged; Prognosis; Retrospective Studies; Ribavirin; Survival Analysis; Treatment Outcome	2015
Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin. Gastroenterology, 2016, Volume: 150, Issue:1 Topics: Antiviral Agents; Chronic Disease; Drug Synergism; Drug Therapy, Combination; Hepatitis E; Hepatitis E virus; Humans; In Vitro Techniques; Ribavirin; RNA, Viral; Sofosbuvir; Virus Replication	2016
Acute Hepatitis E Virus infection with coincident reactivation of Epstein-Barr virus infection in an immunosuppressed patient with rheumatoid arthritis: a case report. BMC infectious diseases, 2015, Oct-29, Volume: 15 Topics: Aged; Arthritis, Rheumatoid; Coinfection; Epstein-Barr Virus Infections; Female; Hepatitis Antibodies; Hepatitis B virus; Hepatitis E; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunosuppressive Agents; Ribavirin	2015
Requirement of the eukaryotic translation initiation factor 4F complex in hepatitis E virus replication. Antiviral research, 2015, Volume: 124 Topics: Animals; Apoptosis Regulatory Proteins; Cell Line, Tumor; DNA Replication; Eukaryotic Initiation Factor-4F; Hepatitis E; Hepatitis E virus; Humans; Interferon-alpha; Mice; Mice, Knockout; Phosphorylation; Protein Biosynthesis; Ribavirin; RNA-Binding Proteins; Viral Proteins; Virus Replication	2015
[Chronic hepatitis caused by hepatitis E virus and treated with ribavirin]. Gastroenterologia y hepatologia, 2016, Volume: 39, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Ascites; Enterobacteriaceae Infections; Female; Hafnia alvei; Hematopoietic Stem Cell Transplantation; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Humans; Immunocompromised Host; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Middle Aged; Ribavirin; Rituximab; Transplantation, Autologous	2016
Mutation in the Hepatitis E Virus Polymerase and Outcome of Ribavirin Therapy. Antimicrobial agents and chemotherapy, 2015, Dec-28, Volume: 60, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Base Sequence; Child; Female; Genetic Markers; Hepatitis E; Hepatitis E virus; Humans; Male; Middle Aged; Mutation; Ribavirin; RNA-Dependent RNA Polymerase; RNA, Viral; Sequence Analysis, RNA; Treatment Outcome; Young Adult	2015
Transmission of Hepatitis E Virus by Plasma Exchange: A Case Report. Annals of internal medicine, 2016, 06-21, Volume: 164, Issue:12 Topics: Antiviral Agents; Female; Hepatitis E; Humans; Immunocompromised Host; Kidney Transplantation; Middle Aged; Plasma Exchange; Ribavirin	2016
Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver. Gut, 2017, Volume: 66, Issue:5 Topics: Animals; Antiviral Agents; Disease Models, Animal; Gene Expression; Genotype; Hepatitis E; Hepatitis E virus; Hepatocytes; Host-Pathogen Interactions; Humans; Liver; Mice; Ribavirin; RNA, Viral; Transplantation Chimera; Viral Load; Viral Proteins	2017
Persisting hepatitis E virus infection leading to liver cirrhosis despite recovery of the immune system in an HIV-infected patient. Clinics and research in hepatology and gastroenterology, 2016, Volume: 40, Issue:3 Topics: Antiviral Agents; DNA, Viral; Hepatitis E; Hepatitis E virus; HIV Infections; Humans; Liver Cirrhosis; Male; Middle Aged; Ribavirin	2016
Management of acute HVE infection in a patient treated with rituximab for rheumatoid arthritis. Joint bone spine, 2016, Volume: 83, Issue:5 Topics: Acute Disease; Antirheumatic Agents; Antiviral Agents; Arthritis, Rheumatoid; Female; Hepatitis E; Humans; Immunocompromised Host; Middle Aged; Ribavirin; Rituximab	2016
In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome. Gut, 2016, Volume: 65, Issue:10 Topics: Adolescent; Adult; Aged; Antiviral Agents; Chronic Disease; Drug Monitoring; Female; Genetic Heterogeneity; Genome, Viral; Hepatitis E; Hepatitis E virus; Humans; Male; Middle Aged; Mutagenesis; Ribavirin	2016
Ribavirin for Chronic Hepatitis E in Liver-Transplant Setting: A Safe and Highly Effective Therapy. Journal of clinical gastroenterology, 2016, Volume: 50, Issue:7 Topics: Adult; Amyloid Neuropathies, Familial; Antiviral Agents; Drug Therapy, Combination; Hepacivirus; Hepatitis E; Hepatitis, Chronic; Hepatolenticular Degeneration; Humans; Interferon-alpha; Liver Transplantation; Ribavirin; Treatment Outcome	2016
Treatment of chronic hepatitis E with ribavirin: lessons from deep sequencing. Gut, 2016, Volume: 65, Issue:10 Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Hepatitis E; Hepatitis, Chronic; High-Throughput Nucleotide Sequencing; Humans; Interferon-alpha; Recombinant Proteins; Ribavirin; Treatment Outcome	2016
Evolution of hepatitis E virus-associated meningo-polyradiculoneuropathy on ribavirin. International journal of antimicrobial agents, 2016, Volume: 48, Issue:3 Topics: Antiviral Agents; Cerebrospinal Fluid; Hepatitis E; Hepatitis E virus; Humans; Male; Meningitis; Middle Aged; Polyradiculoneuropathy; Ribavirin; RNA, Viral; Serum; Treatment Outcome	2016
Sofosbuvir shows antiviral activity in a patient with chronic hepatitis E virus infection. Journal of hepatology, 2017, Volume: 66, Issue:1 Topics: Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Humans; Male; Middle Aged; Ribavirin; Sofosbuvir	2017
[A murine model for an ignored chronic infection: hepatitis E !] Medecine sciences : M/S, 2016, Volume: 32, Issue:10 Topics: Animals; Chronic Disease; Disease Models, Animal; Hepatitis E; Hepatocytes; Heterografts; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Mice, Transgenic; Ribavirin; Urokinase-Type Plasminogen Activator	2016
Exacerbation of hepatitis E virus infection during anti-TNFα treatment. Joint bone spine, 2017, Volume: 84, Issue:2 Topics: Aged; Antirheumatic Agents; Antiviral Agents; Arthritis, Psoriatic; Etanercept; Hepatitis E; Hepatitis, Chronic; Humans; Immunocompromised Host; Male; Ribavirin; Tumor Necrosis Factor-alpha	2017
Chronic hepatitis E in a patient with rheumatoid arthritis treated with adalimumab and methotrexate. Rheumatology (Oxford, England), 2017, Mar-01, Volume: 56, Issue:3 Topics: Adalimumab; Antirheumatic Agents; Antiviral Agents; Arthritis, Rheumatoid; Hepatitis E; Hepatitis, Chronic; Humans; Immunocompromised Host; Male; Methotrexate; Middle Aged; Ribavirin	2017
Hepatitis E Virus Infection after Platelet Transfusion in an Immunocompetent Trauma Patient. Emerging infectious diseases, 2017, Volume: 23, Issue:1 Topics: Adult; Antibodies, Viral; Antiviral Agents; Blood Donors; Blood Platelets; Blood Transfusion; Cholecystitis, Acute; Hepatitis E; Hepatitis E virus; Humans; Male; Platelet Transfusion; Respiratory Distress Syndrome; Ribavirin; Ribs; Shock, Septic; Spleen; Splenectomy; Splenic Rupture	2017
Hepatitis E Virus Infects Neurons and Brains. The Journal of infectious diseases, 2017, 04-15, Volume: 215, Issue:8 Topics: Adult; Aged; Animals; Antiviral Agents; Brain; Cell Line, Tumor; Cerebrospinal Fluid; Female; Guillain-Barre Syndrome; Hepatitis E; Hepatitis E virus; Humans; Interferon-alpha; Liver; Macaca mulatta; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Middle Aged; Neurons; Ribavirin; RNA, Viral; Virus Replication; Virus Shedding	2017
Brief communication: case reports of ribavirin treatment for chronic hepatitis E. Annals of internal medicine, 2010, Jul-20, Volume: 153, Issue:2 Topics: Administration, Oral; Adult; Antiviral Agents; Chronic Disease; Female; Hepatitis E; Humans; Immunocompromised Host; Kidney Transplantation; Male; Middle Aged; Pancreas Transplantation; Ribavirin; T-Lymphocytopenia, Idiopathic CD4-Positive	2010
[Hepatitis E: first steps towards a treatment]. Revue medicale suisse, 2010, Jun-30, Volume: 6, Issue:255 Topics: Antiviral Agents; Hepatitis E; Humans; Immunocompromised Host; Ribavirin	2010
Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection. Gastroenterology, 2010, Volume: 139, Issue:5 Topics: Aged; Antiviral Agents; Chronic Disease; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hepatitis Antibodies; Hepatitis E; Hepatitis E virus; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Pilot Projects; Retrospective Studies; Ribavirin; RNA, Viral; Treatment Outcome; Virus Replication	2010
Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: a role for ribavirin? Journal of hepatology, 2011, Volume: 54, Issue:6 Topics: Adult; Aged; Antiviral Agents; End Stage Liver Disease; Female; France; Genotype; Hepatitis E; Hepatitis E virus; Humans; Male; Middle Aged; Ribavirin; United Kingdom	2011
Sustained virologic response with ribavirin in chronic hepatitis E virus infection in heart transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2011, Volume: 30, Issue:7 Topics: Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Chronic Disease; Follow-Up Studies; Heart Transplantation; Hepatitis E; Humans; Male; Middle Aged; Ribavirin; RNA, Viral; Treatment Outcome	2011
Treatment of severe acute hepatitis E by ribavirin. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2011, Volume: 52, Issue:1 Topics: Acute Disease; Antiviral Agents; Hepatitis Antibodies; Hepatitis E; Humans; Liver; Liver Function Tests; Male; Middle Aged; Ribavirin; RNA, Viral	2011
Definitive clearance of a chronic hepatitis E virus infection with ribavirin treatment. The American journal of gastroenterology, 2011, Volume: 106, Issue:8 Topics: Aged; Alanine Transaminase; Antibodies; Antiviral Agents; Biomarkers; Chronic Disease; Female; Hepatitis E; Hepatitis E virus; Humans; Immunoglobulin A; Immunoglobulin M; Leukemia, Myelomonocytic, Chronic; Ribavirin; Thrombocytopenia; Treatment Outcome; Viral Load	2011
Treatment of chronic hepatitis E in a patient with HIV infection. Annals of internal medicine, 2011, Oct-04, Volume: 155, Issue:7 Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis E; HIV Infections; Humans; Immunocompromised Host; Interferon-alpha; Male; Middle Aged; Ribavirin	2011
Hepatitis E virus-induced severe myositis. Journal of hepatology, 2012, Volume: 57, Issue:5 Topics: Aged; Antiviral Agents; Guillain-Barre Syndrome; Hepatitis E; Hepatitis E virus; Humans; Male; Myositis; Ribavirin; Severity of Illness Index; Treatment Outcome	2012
Chronic hepatitis E after solid organ transplantation. The Netherlands journal of medicine, 2012, Volume: 70, Issue:6 Topics: Animals; Hepatitis E; Hepatitis E virus; Hepatitis, Chronic; Humans; Immunocompromised Host; Ribavirin; RNA, Viral	2012
Ribavirin therapy for hepatitis E virus-induced acute on chronic liver failure: a preliminary report. Antiviral therapy, 2012, Volume: 17, Issue:6 Topics: Adolescent; Antiviral Agents; End Stage Liver Disease; Female; Genotype; Hepatitis E; Hepatitis E virus; Humans; Liver Failure, Acute; Male; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Viral; Treatment Outcome	2012
Hepatitis E: are rheumatic patients at risk? The Journal of rheumatology, 2013, Volume: 40, Issue:1 Topics: Antiviral Agents; Arthritis, Rheumatoid; Hepatitis E; Humans; Male; Middle Aged; Ribavirin; Risk Factors; Treatment Outcome	2013